Navigation Links
Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
Date:8/6/2008

BASKING RIDGE, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today named Mark C. Mirken its new Chief Executive Officer and Chairman of its Board of Directors.

Mirken has been President and Chief Operating Officer of Millennium since he joined the Company in September of 2007. Mirken will replace Jerry Swon who has been Chief Executive Officer and Board Chairman since 2001. Mr. Swon will be retiring from these positions to pursue other business interests.

"In the short time that Mark has been with Millennium he has demonstrated a complete set of business skills and decisive leadership in designing, developing, marketing and selling a Ready-to-Drink product that is gaining significant market acceptance. Mark has created a new and dynamic product and a growing domestic and international customer base. The Agreements he has developed with Ferring Pharmaceuticals of Canada, a division of the international billion dollar drug conglomerate, is the beginning of significant international opportunities. Our three year manufacturing contract with General Electric subsidiary Farmland Dairies will anchor the domestic growth of our Ready-to-Drink product in the immuno-compromised and Long Term Care and Sports Channels. At this point in the Company's history we are extremely fortunate to have a person with Mark's business development capabilities and strategic vision to continue to build and develop the Company's products and line extensions in both its clinical and sports businesses," said Mr. Swon.

"I am extremely excited about the ability to move Millennium in the commercialization of its product lines and leverage and enhance its intellectual assets. I feel strongly that we must shed our past and move quickly to establish beachheads in the lucrative channels we have initiated while concurrently developing similar opportunities i
'/>"/>

SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
2. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
3. MicroMass President Jay Bigelow Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
4. Raj Khankari Named Bioenergy, Inc., CEO
5. Samarion CEO Mark Rodgers Named CAST Commissioner
6. North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S.
7. Quintiles Named to Computerworld Magazines 100 Best Places to Work in Information Technology List
8. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
9. Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
10. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
11. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009).... 6 Helix BioPharma Corp...ounced that John Docherty, president and chief ope...rd,s 6th annual Investor Summit on November 10, 20...y. Mr. Docherty will provide an overview of the C...S47 and Topical Interferon Alpha-2b. The slide sh...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...ideas passed muster in the first round of the Gove...ednesday. , ,They were chosen from 188 submissions...their businesses and represent various municipalit...kee areas. , ,That,s down from 200 entries last ye...gher, chairman of the Wisconsin Technology Council...
...in break Thursday at the Milwaukee County Grounds ...iday to 37 companies in the Milwaukee County Resea...rks director of development said businesses in the...nconvenience. , ,Guy T. Mascari, whose office is l...ation Center, said the center is the only building...
...lor of research in the history of the University o...ng to change its image from a university of access...elp Milwaukee build a knowledge-based economy. , ,...Wisconsins 2006 Technology Achievement Awards, app...ive. Citing Atlanta as a potential model, he said ...
Other Biology Technology:Tech awards keynoter asks for support of UWM transformation 2Tech awards keynoter asks for support of UWM transformation 3
(Date:11/4/2009)..., N.Y., Oct. 21 What,s the cost of...g accidental death resulting from prescription med...good intentions, however, may be unaware that the ...eir teens from the ticking timebomb of prescriptio...in premium-quality medical supplies, has formed an...
(Date:11/4/2009)...APEL HILL Scientists at the University of North C...University of California, San Francisco have devel...ict new target diseases for existing drugs. , Th...t compares how similar the structures of all known...ners -- known as ligands -- of disease targets wit...
(Date:11/3/2009)... RATON, FL (November 4, 2009) For more than 25 ye...en conch ( Strombus gigas ) have been unsuccessful...ry seeding techniques to produce beaded (nucleated...nch have been developed by scientists from Florida... Institute (HBOI). With less than two years of res...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3HPV vaccine could prevent breast cancer 3A Australian research 56154 1HPV vaccine could prevent breast cancer 3A Australian research 56154 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3NIBIB scientists increase imaging efficiency in cell structure studies 56150 1NIBIB scientists increase imaging efficiency in cell structure studies 56150 2
...single vaccine could be used to protect chickens, ...rding to an article published in the November issu...e protects birds and mammals against different flu... are still in their eggs, allowing the mass vaccin...has posed a major challenge to scientists designin...
...In a disease like ALS - one that,s always fatal an...ology - finding a proof of principle in animal mod...searchers report that transplanting a new line of ...e clearly shifts key signs of neurodegenerative di...he animals, neuron loss and extending life. , The...
...searchers at Emory University and Georgia Institut...that can slowly release anti-inflammatory drugs an...jected into rats, hearts after a simulated heart a...nflammation and scarring, the researchers found.,I...tissue formed after the heart attack in half and b...
Other Biology News:Bird flu vaccine protects people and pets 2Swamping bad cells with good in ALS animal models helps sustain breathing 2Swamping bad cells with good in ALS animal models helps sustain breathing 3Drug-embedded microparticles bolster heart function in animal studies 2
Mouse Anti-Human p53, wild & mutant, aa 19-26 Monoclonal Antibody, Unconjugated, Clone DO-7 from CHEMICON
Tube-O-DIALYZER Floats, Floats, Small from CHEMICON
Anti-Feline Rhinotracheitis Virus Monoclonal Antibody, Unconjugated from ViroStat Inc.
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: